Biovator and BASF sign technology development agreement
The Sweden-based biotech company Biovator and the global chemical industry leader BASF have signed a collaboration agreement for final development of In Vitro test systems capable of identifying the potential of chemical compounds to induce allergic reaction in humans. The agreement also includes a five-year BASF option of final product deliveries.“Allergic reactions to compounds are a serious risk in new products that needs to be discovered in the early stages of product development. This collaboration has the potential to open new dimensions in early industrial research that involves